Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06989775 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BoxX-NoAF Clinical Trial

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 27 → 37 locations
    • Eligibility criteria expanded, about 22 words
  2. Primary completion moved earlier from Nov 2028 to Feb 2027
    • Trial sites expanded: 16 → 27 locations
    • Study completion moved earlier from Nov 2031 to Dec 2029
    v6
  3. Trial sites expanded: 10 → 16 locationsv5
  4. Study sites: 8 to 10v4
  5. Study sites: 5 to 8v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 5
    • Start date changed from estimate of Aug 2025 to Oct 24, 2025
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AtriCure, Inc.
9 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Atrial Fibrillation
1,182 trials monitored
See 50 trials at risk
Post Operative Atrial Fibrillation (POAF) is the most common complication of cardiac surgery. POAF incidence can exceed 50% depending on the patient baseline characteristics and surgery type. Patients with POAF tend to have worse acute and long-term clinical outcomes. BoxX-NoAF is a randomized trial to evaluate if prophylactic ablation and exclusion of the Left Atrial Appendage at the time of other routine cardiac surgery can reduce the incidence of post operative AF and clinical AF during long term follow up in patients who have not yet developed AF but are at risk.
Trial Details
NCT Number NCT06989775
Lead Sponsor AtriCure, Inc.
Conditions
(from sponsor)		 Post Operative Atrial Fibrillation, Atrial Fibrillation, Postoperative
Related terms Atrial Fibrillation
Enrollment 960 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov